Liraglutide-13C6,15N (TFA) is a version of Liraglutide labeled with 13C and 15N. Liraglutide acts as a glucagon-like peptide-1 (GLP-1) receptor agonist and is clinically used for the treatment of type 2 diabetes.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
